Event 
Partner 
Milestone 
2018-11-24
ACT Genomics Completed Another Round of Equity Financing
ACT Genomics is pleased to announce the completion of the latest round of equity financing from a group of international investors co-led by CLSA Capital Partners to support the establishment of new CAP-accredited lab in HK, as well as R&D effort.
Place:
2018-11-22
Dr. Allen Lai wins the Executive of the Year – Biotechnology award in Singapore
Dr. Allen Lai, Senior Vice President of ACT Genomics, wins the Executive of the Year – Biotechnology award in Singapore Business Review Management Excellence Awards 2018
Place:
Singapore
2018-11-01
Canon Medical partners with ACT Genomics!
Canon Medical System Corporation officially acquired ACT Genomics’ joint venture company in Japan, ACTmed! ACT Genomics will transfer its clinical NGS technology and help operate cancer genomic profiling service in Japan.
Place:
2018-11-01
Nov 28 Upcoming Asia Pacific Lung Cancer Forum
ACT Genomics and Taiwan Lung Cancer Society will hold Asia Pacific Lung Cancer Forum on November 28th at Taipei W hotel.
Place:
Taipei
2018-11-01
Nov 10-11 Last Call to Register for The Upcoming Annual 5th Hong Kong International Oncology Symposium (5th HKIOS)
ACT Genomics has the invaluable opportunity to be one of the sponsors of the 5th Hong Kong International Oncology Symposium (5th HKIOS) from 10th -11th November 2018 at Hong Kong Science and Technology Park (HKSTP) and City University of Hong Kong (CityU)
Place:
Hong Kong
2018-11-01
Nov 09 Friends of Cancer Research Will Present Initial Findings of TMB Hamonization in Washington, D.C.
MB Harmonization oral presentation titled “In silico assessment of variation in TMB quantification across diagnostic platforms: Phase 1 of the Friends of Cancer Research Harmonization Project “ is scheduled on November 9 th
Place:
USA
2018-11-01
Nov 07-11 ACT Genomics Shares Precision Medicine in Immunotherapy at SITC 2018
ACT Genomics introduced how innovative genomic profiling services can improve immunotherapy reponse rate with predictive biomarkers such as tumor mutational burden (TMB) in The 33rd Annual Meeting & Pre-Conference Programs (SITC 2018)
Place:
USA
2018-11-01
Nov 07 Educational Lecture at Kiang Wu Hospital, Macau on NGS Application to Guide Targeted & Immune Therapeutics by Lab Director of ACTG HK
Dr. Timothy T.C. Yip delivered a talk titled “The New Frontier in Precision Oncology Treatment: How Next-Generation Sequencing (NGS) testing can guide the use of targeted & immune drugs in treatment of cancer patients?”
Place:
Hong Kong
2018-11-01
Nov 06 Upcoming Public Medical Talk: "Where We Stand with Immunotherapy in Lung Cancers" by Dr. Jacky Li
ACT Genomics is proudly sponsoring a medical talk to be given by Dr. Li Yu Chung, Jacky, consultant and specialist in Clinical Oncology from Hong Kong United Oncology Centre
Place:
Hong Kong
2018-11-01
Oct 30 ACT Genomics Scientific Talk at Gleneagles Medini Hospital, Malaysia
ACT Genomics was honoured to be invited to give a scientific talk at Gleneagles Medini Hospital, Johor, Malaysia on 30th October 2018.
Place:
Malaysia
